Theravance Respiratory Company, LLC (Tables)

12 Months Ended

Dec. 31, 2021

Theravance Respiratory Company, LLC

Summary financial information

	Year Ended December 31,
(In thousands)	2021		2020		2019
Current assets	$	93,275	$	63,027	$	36,737
Non-current assets		37,695		16,959		—
Current liabilities		252		508		3,069
Royalty revenue and gross profit		126,688		73,089		42,790
Revenue from collaborative arrangements for the period ended		—		10,000		—
Income from continuing operations		122,732		80,477		39,410
Net income	$	121,191	$	81,662	$	39,653